Cargando…

P1271: ELUCIDATING TUMOR SUPPRESSOR FUNCTIONS OF TET2 IN B CELL LYMPHOMAS

Detalles Bibliográficos
Autores principales:	Kinz, N., Spoeck, S., Leone, M., Lohmueller, M., Villunger, A., Labi, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430866/ http://dx.doi.org/10.1097/01.HS9.0000847948.73228.dc

Ejemplares similares

PB2166: TET ENZYMES PROTECT AGAINST FATAL LYMPHOPROLIFERATION
por: Spoeck, S., et al.
Publicado: (2022)

TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
por: Schoeler, Katia, et al.
Publicado: (2019)

P1304: THE NOVEL TUMOR SUPPRESSOR SAMHD1 CONTRIBUTES TO ANTI-TUMOR RESPONSES IN A CGAS-STING-DEPENDENT OR INDEPENDENT PATHWAY IN HODGKIN LYMPHOMA (HL)
por: Xagoraris, I., et al.
Publicado: (2022)

P1271: THE IMPACT OF CYTOMEGALOVIRUS-SPECIFIC T CELLS USAGE AS ADOPTIVE THERAPY IN PATIENTS WITH PT-CY AND TCR ΑΒ+/CD19+ CELLS DEPLETION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Dmitrova, Anna, et al.
Publicado: (2023)

P993: SETD2 IS A BONA FIDE TUMOR SUPPRESSOR IN SYSTEMIC MASTOCYTOSIS
por: Mancini, M., et al.
Publicado: (2022)

Genome Sequence of Alcaligenes sp. Strain HPC1271
por: Kapley, Atya, et al.
Publicado: (2013)

Expression and role of microRNA-1271 in the pathogenesis of osteosarcoma
por: Lu, Gongbiao, et al.
Publicado: (2018)

Retraction: TET1 exerts its tumor suppressor function by regulating autophagy in glioma cells
Publicado: (2021)

Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates γ irradiation–induced thymic lymphoma development
por: Labi, Verena, et al.
Publicado: (2008)

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA
por: Segura Diaz, A., et al.
Publicado: (2022)

P1211: TUMOR-ACTIVATED LYMPH NODE FIBROBLASTS SUPPRESS T CELL FUNCTION IN DIFFUSE LARGE B CELL LYMPHOMA
por: Apollonio, Benedetta, et al.
Publicado: (2023)

TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia
por: Bensberg, Maike, et al.
Publicado: (2021)

Expression of Concern: TET1 exerts its tumor suppressor function by regulating autophagy in glioma cells
Publicado: (2020)

P1307: TESTING THE IMPORTANCE OF ANTIOXIDANTS ON THE PATHOGENESIS OF B CELL LYMPHOMA
por: Yao, H., et al.
Publicado: (2022)

Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice
por: Woess, C, et al.
Publicado: (2015)

TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion
por: Yu, Shuang, et al.
Publicado: (2020)

miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin
por: Yao, Huixiang, et al.
Publicado: (2019)

Characterising the Transcriptional and Translational Impact of the Schizophrenia-Associated miR-1271-5p in Neuronal Cells
por: Kiltschewskij, Dylan J., et al.
Publicado: (2020)

Clarification of the Three-Body Decay of 12C (12.71 MeV)
por: Fynbo, H O U, et al.
Publicado: (1991)

P1205: PROGNOSTIC ROLE OF TUMOR P53 MUTATION IN DIFFUSE LARGE B CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Ma, J., et al.
Publicado: (2022)

Minor cell death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf
por: Baumgartner, Florian, et al.
Publicado: (2012)

TET1 is a beige adipocyte-selective epigenetic suppressor of thermogenesis
por: Damal Villivalam, Sneha, et al.
Publicado: (2020)

P1283: CIRCULATING IMMUNE CELLS IN CLASSICAL HODGKIN LYMPHOMA IN RELATION TO TUMOR BURDEN AND TREATMENT
por: Mulder, T. A., et al.
Publicado: (2022)

MD1271: Effect of low frequency noise on the evolution of the emittance and halo population
por: Fitterer, Miriam, et al.
Publicado: (2018)

miRNA-1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1
por: Gong, Jian, et al.
Publicado: (2017)

1271. Antimicrobial Appropriateness after Ambulatory Antimicrobial Stewardship Program for Uncomplicated Cystitis
por: Thongwitokomarn, Harit, et al.
Publicado: (2023)

P1212: PERSONALIZED TREATMENT FOR ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Nukariya, H., et al.
Publicado: (2022)

MicroRNA-1271-5p alleviates the malignant development of hepatitis B virus-mediated liver cancer via binding to AQP5
por: Li, Zhigang, et al.
Publicado: (2021)

TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells
por: Fu, Rui, et al.
Publicado: (2017)

P1277: MUTATIONAL LANDSCAPE AND COPY NUMBER ALTERATIONS IN TESTICULAR LARGE B-CELL LYMPHOMA
por: López, C., et al.
Publicado: (2022)

P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS
por: Gurion, R., et al.
Publicado: (2022)

P1235: GENOTYPING ON CIRCULATING TUMOR DNA IMPROVES MUTATION DETECTION RATE IN HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA
por: Xia, Y., et al.
Publicado: (2022)

P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA
por: Vergote, V. K., et al.
Publicado: (2022)

P1196: DIFFERENT MUTATIONS IN PATIENTS WITH PRIMARY LARGE B-CELL LYMPHOMA
por: Kamaeva, I., et al.
Publicado: (2022)

Recurrent TET2 mutations in adult T cell leukemia
por: Marçais, Ambroise, et al.
Publicado: (2014)

Identification and validation of mRNA 3′untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN
por: Roquid, Kenneth Anthony R., et al.
Publicado: (2019)

Elucidating the role of Neuropilin-1 in intra-tumoral regulatory T cell stability
por: Overacre, Abigail E, et al.
Publicado: (2015)

P1287: DISTINGUISHING BETWEEN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA USING THE LYMPH3CX GENE EXPRESSION PROFILING ASSAY
por: Robetorye, R. S., et al.
Publicado: (2022)

P726: TET2 ALLELIC BURDEN IMPRINTS A CONTEXT-DEPENDENT PROGNOSTIC SIGNIFICANCE OF ASXL1 MUTATION IN CHRONIC MYELOMONOCYTIC LEUKAEMIA
por: Wang, Yu-Hung, et al.
Publicado: (2023)

1271. Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Pathogen-Focused Phase 3 CREDIBLE-CR Study
por: Bassetti, Matteo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o4a893mq05dofjn0ksrteb1h02